Inhibitor Therapeutics's total assets for Q were $7.17M, a decrease of -7.97% from the previous quarter. INTI total liabilities were $3.04M for the fiscal quarter, a -3.81% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.